Xi'an International Medical completes share repurchase program

Xi'an International Medical Investment (SZSE:000516) announced the completion of its share repurchase program, initiated in April 2024. The company repurchased 19,304,400 shares, representing 0.8540% of the total share capital, at prices ranging from CNY 4.61 to CNY 5.618 per share, for a total expenditure of CNY 100,019,214.1 (excluding transaction costs). The repurchased shares will be cancelled to reduce the company's registered capital. The repurchase plan, initially funded by company funds, was amended in April 2025 to include dedicated loan facilities, enhancing capital efficiency. All repurchased shares are held in a dedicated securities account and will be retired accordingly. The company's share structure has changed, with non-tradeable shares making up 1.62% of the pie, and leadership-locked shares making up 1.5%. The company will follow standard procedures to reduce the company's registered capital.